CVE-2020-14525

CVE-2020-14525 is a low-severity vulnerability in Philips Clinical Collaboration Platform with a CVSS 3.x base score of 3.5. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-83.

Key facts

Description

Philips Clinical Collaboration Platform, Versions 12.2.1 and prior, does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output used as a webpage that is served to other users.

Frequently asked questions

What is CVE-2020-14525?
Philips Clinical Collaboration Platform, Versions 12.2.1 and prior, does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output used as a webpage that is served to other users.
How severe is CVE-2020-14525?
CVE-2020-14525 has a CVSS 3.x base score of 3.5, rated low severity. It is exploitable over an adjacent network with low attack complexity, requires low privileges and no user interaction. Impact on confidentiality is low, integrity none, and availability none.
Is CVE-2020-14525 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (36th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2020-14525?
CVE-2020-14525 affects Philips Clinical Collaboration Platform. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2020-14525?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
When was CVE-2020-14525 published?
CVE-2020-14525 was published on 2020-09-18 and last updated on 2026-06-17.

References

Affected products (1)

More vulnerabilities in Philips Clinical Collaboration Platform

All CVEs affecting Philips Clinical Collaboration Platform →

Other CWE-83 vulnerabilities

Browse all CWE-83 vulnerabilities →